Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal esketamine premedication for sevoflurane requirement during laryngeal mask airway insertion in children
ChiCTR2300076364Phase 4Not yet recruiting
- Sponsor
- Fujian Provincial Hospital
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine and sevoflurane in strabismus (3 arms), sponsored by Fujian Provincial Hospital. Primary endpoint: Minimum alveolar concentration of sevoflurane for laryngeal mask airway insertion. Planned start Oct 2023; status: not yet recruiting.
02
Drugs
esketaminesevoflurane
03
Conditions
strabismus
Beyond the preview
Go deeper on ChiCTR2300076364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076364.